Schneider Alexander, Michaely Henrik, Weiss Christel, Hirth Michael, Rückert Felix, Wilhelm Torsten J, Schönberg Stefan, Marx Alexander, Singer Manfred V, Löhr J Matthias, Ebert Matthias P, Pfützer Roland H
Department of Medicine II, University Medical Centre Mannheim, Medical Faculty of the University of Heidelberg, Mannheim, Germany.
Digestion. 2017 Nov;96(4):187-198. doi: 10.1159/000479316. Epub 2017 Sep 29.
BACKGROUND/AIMS: The prevalence and incidence of autoimmune pancreatitis (AiP) in those living in western countries are largely unknown. We aimed to determine the prevalence of AiP among patients with pancreatitis presenting to our tertiary referral center in Mannheim, Germany; and to estimate the incidence of AiP in the Southwest of Germany.
We performed a retrospective cross-sectional analysis and determined the prevalence of AiP in patients with acute pancreatitis (AP) or chronic pancreatitis (CP). Patients (n = 704; alcoholic pancreatitis n = 373, nonalcoholic pancreatitis n = 331) were stratified into the Retrospective-Pancreas-Cohort (RPC, period 1998-2008, n = 534) and the Pancreas-Clinic-Cohort (PCC, periods 2008-2010 and 2013-2014, n = 170, with detailed investigation for features of AiP). Diagnosis of AiP was established by International-Consensus-Diagnostic-Criteria and Unifying-Autoimmune-Pancreatitis-Criteria.
In the RPC, the prevalence of AiP was 5.9% (n = 13/221) among individuals with nonalcoholic pancreatitis (n = 1/61 with AP, 1.6%; n = 12/160 with CP, 7.5%). In the PCC, the prevalence of AiP was 9.1% (n = 10/110) among patients with nonalcoholic pancreatitis (n = 2/24 with AP, 8.3%; n = 8/86 with CP, 9.3%), and 1.7% (n = 1/60) among subjects with alcoholic pancreatitis. We estimated the incidence of AiP with 0.29 per 100,000 population each year.
The prevalence rate of AiP may account for 9% of patients with nonalcoholic pancreatitis but is almost never observed in patients with alcoholic pancreatitis. The incidence of AiP in Germany appears lower than 1 per 100,000 population.
背景/目的:西方国家自身免疫性胰腺炎(AiP)的患病率和发病率大多未知。我们旨在确定德国曼海姆三级转诊中心胰腺炎患者中AiP的患病率;并估算德国西南部AiP的发病率。
我们进行了一项回顾性横断面分析,确定急性胰腺炎(AP)或慢性胰腺炎(CP)患者中AiP的患病率。患者(n = 704;酒精性胰腺炎n = 373,非酒精性胰腺炎n = 331)被分为回顾性胰腺队列(RPC,1998 - 2008年,n = 534)和胰腺临床队列(PCC,2008 - 2010年和2013 - 2014年,n = 170,对AiP特征进行详细调查)。AiP的诊断依据国际共识诊断标准和统一自身免疫性胰腺炎标准。
在RPC中,非酒精性胰腺炎患者中AiP的患病率为5.9%(n = 13/221)(AP患者中1/61,1.6%;CP患者中12/160,7.5%)。在PCC中,非酒精性胰腺炎患者中AiP的患病率为9.1%(n = 10/110)(AP患者中2/24,8.3%;CP患者中8/86,9.3%),酒精性胰腺炎患者中为1.7%(n = 1/60)。我们估算AiP的发病率为每年每10万人0.29例。
AiP的患病率可能占非酒精性胰腺炎患者的9%,但在酒精性胰腺炎患者中几乎从未观察到。德国AiP的发病率似乎低于每10万人1例。